84 related articles for article (PubMed ID: 38651817)
1. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174
[TBL] [Abstract][Full Text] [Related]
2. Pericytes Are Immunoregulatory Cells in Glioma Genesis and Progression.
Martinez-Morga M; Garrigos D; Rodriguez-Montero E; Pombero A; Garcia-Lopez R; Martinez S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791110
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of HLA-II related to LAG-3
Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
[TBL] [Abstract][Full Text] [Related]
5. IFI35 regulates non-canonical NF-κB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophages.
Li D; Wang X; Chen K; Shan D; Cui G; Yuan W; Lin Q; Gimple RC; Dixit D; Lu C; Gu D; You H; Gao J; Li Y; Kang T; Yang J; Yu H; Song K; Shi Z; Fan X; Wu Q; Gao W; Zhu Z; Man J; Wang Q; Lin F; Tao W; Mack SC; Chen Y; Zhang J; Li C; Zhang N; You Y; Qian X; Yang K; Rich JN; Zhang Q; Wang X
Cell Death Differ; 2024 Jun; 31(6):738-752. PubMed ID: 38594444
[TBL] [Abstract][Full Text] [Related]
6. Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells.
Peres N; Lepski GA; Fogolin CS; Evangelista GCM; Flatow EA; de Oliveira JV; Pinho MP; Bergami-Santos PC; Barbuto JAM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791312
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.
Nóbrega AHL; Pimentel RS; Prado AP; Garcia J; Frozza RL; Bernardi A
Curr Cancer Drug Targets; 2024; 24(6):579-594. PubMed ID: 38310461
[TBL] [Abstract][Full Text] [Related]
8. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective.
Wang L; Li X; Xu C; Wang D; Ma C; Wang Z; Li Y; Li Z
J Transl Med; 2024 Jun; 22(1):551. PubMed ID: 38851695
[TBL] [Abstract][Full Text] [Related]
9. Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab.
Wang F; Liao W; Li C; Zhu L
Int Immunopharmacol; 2024 Jun; 134():112187. PubMed ID: 38733825
[TBL] [Abstract][Full Text] [Related]
10. CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma.
Wang J; Li X; Wang K; Li K; Gao Y; Xu J; Peng R; Zhang X; Zhang S; Zhou Y; Xu S; Zhang J
Front Immunol; 2024; 15():1361351. PubMed ID: 38846954
[TBL] [Abstract][Full Text] [Related]
11. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients.
Harshyne LA; Nasca BJ; Kenyon LC; Andrews DW; Hooper DC
Neuro Oncol; 2016 Feb; 18(2):206-15. PubMed ID: 26180083
[TBL] [Abstract][Full Text] [Related]
12. Why Don't the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment.
Mohapatra S; Cafiero J; Kashfi K; Mehta P; Banerjee P
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902456
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of tumor-associated macrophages in cervical cancer].
Li D; Lu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):472-478. PubMed ID: 38790105
[TBL] [Abstract][Full Text] [Related]
14. Non-Tumor Cells within the Tumor Microenvironment-The "Eminence Grise" of the Glioblastoma Pathogenesis and Potential Targets for Therapy.
Bugakova AS; Chudakova DA; Myzina MS; Yanysheva EP; Ozerskaya IV; Soboleva AV; Baklaushev VP; Yusubalieva GM
Cells; 2024 May; 13(10):. PubMed ID: 38786032
[TBL] [Abstract][Full Text] [Related]
15. TREM2 function in glioblastoma immune microenvironment: Can we distinguish reality from illusion?
Ghosh S; Rothlin CV
Neuro Oncol; 2024 May; 26(5):840-842. PubMed ID: 38290471
[No Abstract] [Full Text] [Related]
16. Spatial analysis of recurrent glioblastoma reveals perivascular niche organization.
Onubogu U; Gatenbee CD; Prabhakaran S; Wolfe K; Oakes B; Salatino R; Vaubel R; Szentirmai O; Anderson ARA; Janiszewska M
JCI Insight; 2024 May; ():. PubMed ID: 38805346
[TBL] [Abstract][Full Text] [Related]
17. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.
Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S
Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817
[TBL] [Abstract][Full Text] [Related]
18. Combining Magnetic Resonance Imaging with Systemic Monocyte Evaluation for the Implementation of GBM Management.
Giordano C; Sabatino G; Romano S; Della Pepa GM; Tufano M; D'Alessandris QG; Cottonaro S; Gessi M; Balducci M; Romano MF; Olivi A; Gaudino S; Colosimo C
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917598
[TBL] [Abstract][Full Text] [Related]
19. Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients.
Troiani T; Giunta EF; Tufano M; Vigorito V; Arrigo P; Argenziano G; Ciardiello F; Romano MF; Romano S
Br J Cancer; 2020 Jun; 122(12):1782-1790. PubMed ID: 32317723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
